Kidofen Duo

Ibuprofen and Paracetamol, the active ingredients in Kidofen Duo, are a combination NSAID/Analgesic presented as an oral tablet for oral use. They provide pain relief and fever reduction in children and adults requiring dual-action therapy. It is commonly employed for short‑term management of mild to moderate discomfort.

GNH USA supplies Kidofen Duo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution across regions.

Kidofen Duo, a combination NSAID/analgesic, is indicated for conditions where pain or fever are present.

- Pain relief: alleviates mild to moderate pain such as headache, toothache or postoperative discomfort. - Fever reduction: lowers elevated body temperature in febrile states. - Headache: provides rapid relief of tension‑type or mild migraine pain. - Musculoskeletal pain: eases discomfort associated with strains, sprains or arthritis.

Kidofen Duo may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or mild abdominal pain that usually resolves without treatment. - Headache: transient headache may occur, often mild and self‑limiting. - Dizziness: occasional light‑headedness or vertigo, typically short‑lasting. - Skin rash: mild erythematous rash or itching, generally reversible after discontinuation.

Serious or Rare Side Effects: - Gastrointestinal bleeding: ulceration or hemorrhage that can present as black stools or vomiting blood. - Severe allergic reaction: anaphylaxis, facial swelling, hives, or bronchospasm requiring immediate medical attention. - Hepatotoxicity: elevated liver enzymes or clinically significant liver injury, especially with overdose or chronic use. - Renal impairment: acute kidney injury, particularly in patients with dehydration or pre‑existing renal disease.

When using Kidofen Duo, several precautions should be observed to ensure safe administration.

- Assess renal function: evaluate kidney status before use, especially in patients with chronic renal disease. - Avoid in known hypersensitivity: do not use if the patient has allergy to ibuprofen, paracetamol or any excipients. - Limit concurrent alcohol intake: alcohol may increase risk of liver injury and gastrointestinal irritation. - Monitor liver enzymes: prolonged high‑dose therapy may affect hepatic function, requiring periodic testing. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Kidofen Duo can interact with other medicines; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - High‑dose corticosteroids: heightened ulcer risk. - Methotrexate: reduced clearance leading to toxicity.

Moderate Interactions (Monitor Closely): - Diuretics: may reduce renal perfusion, increasing risk of kidney injury. - ACE inhibitors or ARBs: possible decline in renal function when combined. - Lithium: increased serum lithium levels, risk of toxicity. - Alcohol: enhanced hepatotoxic potential.